PNRC1: A Proline-rich Protein with Potential as A Drug Target

Target Name: PNRC1

NCBI ID: G10957

PNRC1

PNRC1: A Proline-rich Protein with Potential as A Drug Target

Proline-rich protein 2 (PNRC1) is a protein that is expressed in various tissues throughout the body, including the brain, muscle, and heart. It is a protein that is known for its unique structure, as it is composed of a series of proline-rich repeats that are arranged in a specific pattern.

One of the unique features of PNRC1 is its ability to interact with other proteins, particularly the protein known as neurotrophin (NTGF), which is a critical signaling molecule in the brain. The interaction between PNRC1 and NTGF has been shown to play a role in a variety of physiological processes, including the regulation of brain development and the maintenance of muscle mass.

In addition to its role in interacting with NTGF, PNRC1 has also been shown to interact with a variety of other proteins, including the protein known as Tau. Tau is a protein that is involved in the regulation of various cellular processes, including cell division and the development of neurodegenerative diseases. The interaction between PNRC1 and Tau has been shown to contribute to the development and progression of neurodegenerative diseases.

PNRC1 has also been shown to interact with the protein known as FBN1, which is a protein that is involved in the regulation of blood clotting. The interaction between PNRC1 and FBN1 has been shown to play a role in the regulation of blood clotting and the risk of cardiovascular disease.

In addition to its role in interacting with other proteins, PNRC1 has also been shown to have its own unique biology. For example, studies have shown that PNRC1 is expressed in the brain and that it is involved in the regulation of various brain developmental processes. Additionally, PNRC1 has been shown to play a role in the regulation of muscle mass and function, as well as the regulation of inflammation.

Despite its unique biology, PNRC1 has not yet been studied extensively, and much of its function and potential as a drug target remains unexplored. However, the interaction between PNRC1 and NTGF, as well as its interaction with Tau and FBN1, suggests that it may be a promising target for the development of new treatments for a variety of neurodegenerative diseases. Further research is needed to fully understand the biology of PNRC1 and its potential as a drug target.

Protein Name: Proline Rich Nuclear Receptor Coactivator 1

Functions: Nuclear receptor coactivator. May play a role in signal transduction

The "PNRC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PNRC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets